IN-DATE
04364: LivaNova Xtra Blood Processing Autotransfusion Procedure Set, BX/225ml, Filtered 40um Bottom Outlet
Sign in to add this product to your favorites!
| Price: | $399.00 per kit |
|---|---|
| Quantity: | |
| In Stock: | 1 kits |
| Expiration: | 05-2028 |
Additional Details
LivaNova Xtra Blood Processing Autotransfusion Procedure Set
The XTRA Autotransfusion System is indicated for intraoperative and postoperative recovery of blood, washing of the processed blood and preoperative sequestration (with indirect patient connection). Typical clinical applications of autotransfusion include the following surgical specialties: Cardiovascular, Orthopedics, Thoracic, Transplant Surgery, Emergency (Trauma), Neurosurgery, Obstetrics and Gynecology, and Urology. The XVAC is indicated for use only with the XTRA, an autologous blood recovery system indicated for intra-and post-operative autotransfusion, as well as for pre-operative sequestration.
Product Code: 04364
- Bowl Set 225ml
- Blood Collection Reservoir, Filtered 40um, Bottom Outlet
- Vacuum Extension Line
- Aspiration and Anticoagulation Line 1/4"
AccessGUDID Info
- FDA Product Code: CAC
- FDA Product Code Name: Apparatus, autotransfusion
- FDA Product Code: DTN
- FDA Product Code Name: Reservoir, blood, cardiopulmonary bypass
- GMDN Term Code: 17605
- GMDN Term Name: Autotransfusion system blood component processing set
- GMDN Term Description: A collection of noninvasive devices that typically includes tubing, containers (e.g., bags or bowls for treatment, reinfusion, waste disposal) and filters intended to be used to process (filter/wash) blood components (e.g., red or white blood cells, platelets) in conjunction with a dedicated pump (not included) as part of an autotransfusion procedure; it is not dedicated to suction and/or anticoagulation. This is a single-use device.
Manufacturer
LivaNova PLC is a global leader in medical technology, specializing in innovative solutions for cardiac surgery, neuromodulation, and cardiopulmonary support. Headquartered in London, England, and with operations worldwide, LivaNova combines decades of expertise with cutting-edge research to develop life-changing devices and therapies. Its diverse portfolio includes advanced systems for heart-lung machines, implantable neuromodulation devices for epilepsy and depression, and solutions for managing heart valve and coronary conditions. Renowned for its commitment to improving patient outcomes and enhancing quality of life, LivaNova collaborates closely with healthcare professionals to drive innovation and deliver exceptional care in the treatment of complex conditions.
